Filter By:
April 22, 2021Client News
Overtime Raises $80M Series C Financing

Gunderson Dettmer represented client Overtime, a sports media company, in its $80 million Series C financing from investors including Jeff Bezos, Drake, Reddit co-founder Alexis Ohanian and several National Basketball Association players.

More
April 15, 2021Client News
Medrio Acquisition of HMD Clinical

Gunderson Dettmer represented client Medrio, a leading provider of eClinical technology to pharmaceutical, biotech, medical device, diagnostics, and animal health markets, in its acquisition of HMD Clinical.

More
April 15, 2021Client News
图森未来成功登陆纳斯达克 高锐担任发行人律师

2021年4月15日,自动驾驶卡车公司图森未来(TuSimple Holdings Inc.)宣布在美国纳斯达克全球精选市场成功上市,股票代码“TSP”,发行价为40美元每股,公司募集资金总额超过10亿美元,成为“全球自动驾驶第一股”。

More
April 7, 2021Client News
Carta Healthcare Raises $17.3M Series A Financing

Gunderson Dettmer represented client Carta Healthcare, a provider of AI-powered clinical data abstraction technology and services, in its $17.3 million Series A financing led by Storm Ventures.

More
April 6, 2021Client News
Kavak Raises $485M Series D Financing

Gunderson Dettmer represented client Kavak, an online platform for buying and selling secondhand cars, in its $485 million Series D financing, bringing the company’s valuation to $4 billion.

More
April 2, 2021Client News
Anduril Acquisition of Area-I

Gunderson Dettmer represented client Anduril Industries, a defense technology provider, in its acquisition of Area-I.

More
March 31, 2021Client News
Betty Labs Acquisition by Spotify

Gunderson Dettmer represented client Betty Labs, a tech startup that created Locker Room, a live audio app for sports fans, in its acquisition by Spotify.

More
March 30, 2021Client News
Pyxis Raises $152M Series B Financing

Gunderson Dettmer represented client Pyxis Oncology, a developer of antibody therapeutics to further improve the outcome for patients with cancer, in its $152 million Series B financing co-led by Arix Bioscience and RTW Investments.

More
March 29, 2021Client News
Cityblock Raises $192M Series C-2 Financing

Gunderson Dettmer represented client Cityblock Health, a startup improving health care for low-income patients with complex medical needs, in its $192 million Series C-2 financing led by Tiger Global.

More
March 29, 2021Client News
Tarsus Pharmaceuticals Strategic Partnership with LianBio

Gunderson Dettmer represented client Tarsus Pharmaceuticals, Inc., a late clinical-stage biopharmaceutical company, in its strategic partnership with LianBio to develop and commercialize its investigational therapeutic for eye conditions, TP-03, in Greater China.

More
March 25, 2021Client News
Khatabook Acquisition of Biz Analyst

Gunderson Dettmer represented client Khatabook, an India-based fintech company, in its $10 million acquisition of Biz Analyst, a software-as-a-service business management firm.

More
March 10, 2021Client News
Corvus Raises $100M Series C Financing

Gunderson Dettmer represented client Corvus Insurance, a leading provider of smart commercial insurance products powered by AI-driven risk data, in its $100 million Series C financing led by Insight Partners.

More
March 1, 2021Client News
Turntide Acquisition of Riptide

Gunderson Dettmer represented client Turntide Technologies, an electric motor system with digital DNA, in its acquisition of Riptide.

More
February 25, 2021Client News
Foresite Capital Closes Fifth Fund

Gunderson Dettmer represented Foresite Capital in the formation of the fund’s fifth fund, which is comprised of two separate investment vehicles, Foresite Capital Fund V and Foresite Capital Opportunity Fund V.

More
February 25, 2021Client News
Newsela Raises $100M Series D Financing

Gunderson Dettmer represented client Newsela, a SaaS platform for K-12 instructional material, in its $100 million Series D financing led by Franklin Templeton.

More